rediff.com

NewsApp (Free)

Read news as it happens
Download NewsApp

Available on  

Rediff News  All News 

Gleevec

Rediff.com  »  News  »   Gleevec

  News for Gleevec

  • Business

Sun Pharma settles litigation with Novartis over cancer drug

Sun Pharma has inked a settlement pact with Novartis Pharmaceutical Corporation over cancer drug Gleevec, paving the way for the Indian drug major to launch a generic version of the medicine in the......

Sun Pharma sues Novartis in US court

In a development that could hasten the entry of the generic version of Gleevec into the US market, Indian drug major Sun Pharma has sued Novartis Pharmaceuticals Corp in the District Court of New......

Novartis denied patent for cancer drug

The Patent Controller Office of India has rejected the patent application of Novartis AG for its cancer drug Gleevec.Assistant Controller of Patents & Designs V Rengasamy rejected the application......

Weak oil prices drag markets; Nifty ends below 7,400

Financials were the top losers while oil shares also declined amid weak crude oil prices. Benchmark share indices extended losses for the third straight session dragged by financials while oil......

How some SC judgements changed the game for corporate India

The 1995 judgment in the Union of India vs Cricket Association of Bengal case emphasised that free speech is essential for a successful democracy and citizens must have a plurality of views and a......
  Web results for Gleevec
Five trends to watch out from Indian drugmakers

Analysts predict Q3 to be a tough quarter with revenue growth moderating to 11.7 percent in October-December period compared to 18.4 percent... ...

http://www.moneycontrol.com/news/business/q3-results-five-trends-to-watch-outindian-drugmakers_8268581.html
Morgan Stanley rates Sun Pharmaceutical Industries Equal-Weight

Sun continues to bolster its specialty pipeline—Tildrakizumab (Merck), Odomzo (Novartis), MM-II (Moebius), Seciera (Ocular), Elepsia/Xelpros... ...

http://www.financialexpress.com/industry/morgan-stanley-rates-sun-pharmaceutical-industries-equal-weight/502309/
Price Control Won't Make Stents More Accessible

Why is it that there are just a handful of manufacturers and of those, a very insignificant number are Indian owned? Is there a need for a... ...

http://www.bloombergquint.com/opinion/2017/01/03/price-control-wont-make-stents-more-accessible
Colombia cuts price of Novartis cancer drug by 44 percent

BOGOTA (Reuters) - Colombia's government has lowered the price of Novartis cancer drug imatinib by nearly half in a bid to cut healthcare costs... ...

https://in.news.yahoo.com/colombia-cuts-price-novartis-cancer-drug-44-percent-134821417.html
Global Hematological Cancers Market to 2022 Commercially Successful Targeted Therapies and Large, Innovative Pipeline to Drive Market

MRRS adds "Global Hematological Cancers Market to 2022 Commercially Successful Targeted Therapies and Large, Innovative Pipeline to Drive Market"... ...

http://pressreleaseping.com/pressrelease/220769.html

Related Tags


  1. gujarat
  2. bjp
  3. india
  4. lok sabha
  5. supreme court
  6. upa
  7. bharatiya janata party
  8. congress
  9. new delhi
  10. united progressive alliance
  11. ahmedabad
  12. sonia gandhi
  13. nda
  14. rahul gandhi
  15. rajnath singh
  16. nitin gadkari
  17. delhi
  18. manmohan singh
  19. bihar
  20. national democratic alliance
  21. jd-u
  22. nitish kumar
  23. rashtriya swayamsevak sangh
  24. uttar pradesh
  25. photo
  26. advani
  27. central bureau of investigation
  28. rss
  29. janata dal-united
  30. ips

Related Pages


gleevec
Buy Generic Gleevec Online

For Buying Imatinib & Gleevec Online...
1 Followers

gleevec
Buy Generic Gleevec 100mg Online

Gleevec 100mg tablets are a new type...
1 Followers

gleevec
Buy Generic Gleevec 400mg Tablets Online

Imatinib mesylate 400mg tablets is a...
1 Followers

Top Coverage News


Coming to India and making

Success in manufacturing is not just about being cheap - cheap labour, cheap land, cheap power...
Broswe by: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z